Matches in Wikidata for { <http://www.wikidata.org/entity/Q66407170> ?p ?o ?g. }
Showing items 1 to 45 of
45
with 100 items per page.
- Q66407170 description "clinical trial" @default.
- Q66407170 description "ensayu clínicu" @default.
- Q66407170 description "klinisch onderzoek" @default.
- Q66407170 description "клінічне випробування" @default.
- Q66407170 name "Safety and Efficacy Study of Injectable Cabotegravir Compared to Daily Oral Tenofovir Disoproxil Fumarate/Emtricitabine (TDF/FTC), For Pre-Exposure Prophylaxis in HIV-Uninfected Cisgender Men and Transgender Women Who Have Sex With Men" @default.
- Q66407170 name "Safety and Efficacy Study of Injectable Cabotegravir Compared to Daily Oral Tenofovir Disoproxil Fumarate/Emtricitabine (TDF/FTC), For Pre-Exposure Prophylaxis in HIV-Uninfected Cisgender Men and Transgender Women Who Have Sex With Men" @default.
- Q66407170 type Item @default.
- Q66407170 label "Safety and Efficacy Study of Injectable Cabotegravir Compared to Daily Oral Tenofovir Disoproxil Fumarate/Emtricitabine (TDF/FTC), For Pre-Exposure Prophylaxis in HIV-Uninfected Cisgender Men and Transgender Women Who Have Sex With Men" @default.
- Q66407170 label "Safety and Efficacy Study of Injectable Cabotegravir Compared to Daily Oral Tenofovir Disoproxil Fumarate/Emtricitabine (TDF/FTC), For Pre-Exposure Prophylaxis in HIV-Uninfected Cisgender Men and Transgender Women Who Have Sex With Men" @default.
- Q66407170 prefLabel "Safety and Efficacy Study of Injectable Cabotegravir Compared to Daily Oral Tenofovir Disoproxil Fumarate/Emtricitabine (TDF/FTC), For Pre-Exposure Prophylaxis in HIV-Uninfected Cisgender Men and Transgender Women Who Have Sex With Men" @default.
- Q66407170 prefLabel "Safety and Efficacy Study of Injectable Cabotegravir Compared to Daily Oral Tenofovir Disoproxil Fumarate/Emtricitabine (TDF/FTC), For Pre-Exposure Prophylaxis in HIV-Uninfected Cisgender Men and Transgender Women Who Have Sex With Men" @default.
- Q66407170 P1132 Q66407170-1F8C250C-A5D2-4329-A438-82252CC9DAAC @default.
- Q66407170 P1476 Q66407170-9E04806B-ACE1-4823-BC15-A6B6593088F4 @default.
- Q66407170 P17 Q66407170-1B90DBC7-7372-4427-8544-235BB4BA68CB @default.
- Q66407170 P17 Q66407170-39444045-1D84-48D4-AFA9-7743BB46D61B @default.
- Q66407170 P17 Q66407170-4614F79B-BD53-4A8D-8389-36B76CF9D944 @default.
- Q66407170 P17 Q66407170-52CE93EB-A5A6-43EA-AE0B-BCCFA1BF84F1 @default.
- Q66407170 P17 Q66407170-56204365-B555-44CE-B268-B65302DFFE4E @default.
- Q66407170 P17 Q66407170-AB3FB97D-E231-4F7C-AFCC-DA430F09F552 @default.
- Q66407170 P17 Q66407170-DA7E4C14-A787-419B-B4BA-9C3D2A58CE8B @default.
- Q66407170 P2899 Q66407170-006A17CE-2F6A-485D-822D-D32D143D3DA4 @default.
- Q66407170 P3098 Q66407170-1FF9B49F-F00A-4F25-9BBC-4FDD56FA8F06 @default.
- Q66407170 P31 Q66407170-BB39EE0F-DA65-4801-84E7-06EA7A0F5553 @default.
- Q66407170 P580 Q66407170-642C5379-B2B2-44D5-8F0D-12A443FA3233 @default.
- Q66407170 P582 Q66407170-59A73F79-24B8-40D1-910F-814223781C79 @default.
- Q66407170 P6099 Q66407170-74BA3DE7-E992-4B06-AEF3-C7C058B16291 @default.
- Q66407170 P6099 Q66407170-A569362C-E15D-45ED-B48D-3686A4E00D7A @default.
- Q66407170 P8363 Q66407170-DE7217B7-A9BD-4FED-9AE9-ED0C48E99058 @default.
- Q66407170 P1132 "+4500" @default.
- Q66407170 P1476 "A Phase 2b/3 Double Blind Safety and Efficacy Study of Injectable Cabotegravir Compared to Daily Oral Tenofovir Disoproxil Fumarate/Emtricitabine (TDF/FTC), For Pre-Exposure Prophylaxis in HIV-Uninfected Cisgender Men and Transgender Women Who Have Sex With Men" @default.
- Q66407170 P17 Q155 @default.
- Q66407170 P17 Q258 @default.
- Q66407170 P17 Q30 @default.
- Q66407170 P17 Q414 @default.
- Q66407170 P17 Q419 @default.
- Q66407170 P17 Q869 @default.
- Q66407170 P17 Q881 @default.
- Q66407170 P2899 "+18" @default.
- Q66407170 P3098 "NCT02720094" @default.
- Q66407170 P31 Q30612 @default.
- Q66407170 P580 "2016-12-01T00:00:00Z" @default.
- Q66407170 P582 "2022-03-30T00:00:00Z" @default.
- Q66407170 P6099 Q42824440 @default.
- Q66407170 P6099 Q42824827 @default.
- Q66407170 P8363 Q78089383 @default.